ArticleJournal of pharmaceutical policy and practice2023
ChatGPT in pharmacy practice: a cross-sectional exploration of Jordanian pharmacists' perception, practice, and concerns.
Article in Journal of pharmaceutical policy and practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Integrating Large Language Models Into UAE Community Pharmacies: Pharmacists' Perspectives on Benefits, Concerns, and Implementation Barriers.International journal of telemedicine and applications · 2026Article
- Artificial intelligence in pharmacy practice: pharmacists' perceptions and concerns toward implementation.Frontiers in digital health · 2026Article
- Artificial intelligence tool utilization in deprescribing practices among community pharmacists in Jordan: a cross-sectional study.Frontiers in digital health · 2026Article
- Pharm D student's Knowledge, perception, and practice of CHAT-GPT in clinical training: a web-based cross-sectional survey in India.Scientific reports · 2025Article
- Assessing Pharmacists' Use and Perception of AI Chatbots in Pharmacy Practice: Cross-Sectional Survey Study.JMIR medical education · 2025Article
- Article
- Leveraging In Silico and Artificial Intelligence Models to Advance Drug Disposition and Response Predictions Across the Lifespan.Clinical and translational science · 2025Review
- Development of an artificial intelligence-enhanced warfarin interaction checker platform.PLOS digital health · 2025Article
- The extent and type of use, opportunities and concerns of ChatGPT in community pharmacy: A survey of community pharmacy staff.Exploratory research in clinical and social pharmacy · 2025Article
- Exploring medical students' intention to use of ChatGPT from a programming course: a grounded theory study in China.BMC medical education · 2025Article
- Knowledge, attitude, and perceptions of MENA researchers towards the use of ChatGPT in research: A cross-sectional study.Heliyon · 2025Article
- Knowledge, use and perceptions of artificial intelligence Chatbots among Italian physiotherapists: an online cross-sectional survey.Frontiers in digital health · 2025Article
- Integrating ChatGPT as a Tool in Pharmacy Practice: A Cross-Sectional Exploration Among Pharmacists in Saudi Arabia.Integrated pharmacy research & practice · 2025Article
- Comparative evaluation of artificial intelligence systems' accuracy in providing medical drug dosages: A methodological study.World journal of methodology · 2024Article
- Capturing pharmacists' perspectives on the value, risks, and applications of ChatGPT in pharmacy practice: A qualitative study.Exploratory research in clinical and social pharmacy · 2024Article
- Perception, concerns, and practice of ChatGPT among Egyptian pharmacists: a cross-sectional study in Egypt.BMC health services research · 2024Article
- Engine of Innovation in Hospital Pharmacy: Applications and Reflections of ChatGPT.Journal of medical Internet research · 2024Article
- Ethical considerations and concerns in the implementation of AI in pharmacy practice: a cross-sectional study.BMC medical ethics · 2024Article
- Detecting manuscripts written by generative AI and AI-assisted technologies in the field of pharmacy practice.Journal of pharmaceutical policy and practice · 2024Article
- Exploring Jordanian medical students' perceptions and concerns about ChatGPT in medical education: a cross-sectional study.Journal of pharmaceutical policy and practice · 2024Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe purpose of this study is to find out how much pharmacists know and have used ChatGPT in their practice. We investigated the advantages and disadvantages of utilizing ChatGPT in a pharmacy context, the amount of training necessary to use it proficiently, and the influence on patient care using a survey.
methodsThis cross-sectional study was carried out between May and June 2023 to assess the potential and problems that pharmacists observed while integrating chatbots powered by AI (ChatGPT) in pharmacy practice. The correlation between perceived benefits and concerns was evaluated using Spearman's rho correlation due to the data's non-normal distribution.Any pharmacists licensed by the Jordanian Pharmacists Association were included in the study. A convenient sampling technique was used to choose the participants, and the study questionnaire was distributed utilizing an online medium (Facebook and WhatsApp). Anyone who expressed interest in taking part was given a link to the study's instructions so they may read them before giving their electronic consent and accessing the survey.
resultsThe potential advantages of ChatGPT in the pharmacy practice were widely acknowledged by the participants. The majority of participants (69.9%) concurred that educational material about pharmacy items or therapeutic areas can be provided using ChatGPT, with 66.9% of respondents believing that ChatGPT is a machine learning algorithm. Concerns about the accuracy of AI-generated responses were also prevalent. More than half of the participants (55.7%) raised the possibility that AI systems such as ChatGPT could pick up on and replicate prejudices and discriminatory patterns from the data they were trained on. Analysis shows a statistically significant positive link, albeit a minor one, between the perceived advantages of ChatGPT and its drawbacks (r = 0.255, p < 0.001). However, concerns were strongly correlated with knowledge of ChatGPT. In contrast to those who were either unsure or had not heard of ChatGPT (64.2%), individuals who had heard of it were more likely to have strong concerns (79.8%) (p = 0.002). Finally, the results show a statistically significant association between the frequency of ChatGPT use and positive perceptions of the tool (p < 0.001).
conclusionsAlthough ChatGPT has shown promise in health and pharmaceutical practice, its application should be rigorously regulated by evidence-based law. According to the study's findings, pharmacists support the use of ChatGPT in pharmacy practice but have concerns about its use due to ethical reasons, legal problems, privacy concerns, worries about the accuracy of the data generated, data learning, and bias risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.